Janus Henderson Group Plc

13F Holdings History for Verona Pharma plc - Ordinary Shares, nominal value GBP0.05 per share (VRNA)

Symbol: VRNA on Nasdaq
Investment type: Equity / Ordinary Shares, nominal value GBP0.05 per share
Latest Disclosed Ownership: 6.13M shares
Security Ownership: 7.2%

Shares, Excluding Options vs Price

Value, Excluding Options

JANUS HENDERSON GROUP PLC ownership in Verona Pharma plc Ordinary Shares, nominal value GBP0.05 per share (VRNA)

2025-08-14 - JANUS HENDERSON GROUP PLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.13M shares of Verona Pharma plc Ordinary Shares, nominal value GBP0.05 per share (VRNA). This represents 7.2% percent ownership of the company. In their previous filing dated 2025-05-14, JANUS HENDERSON GROUP PLC had reported owning 5.54M shares, indicating an increase of 10.7% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
JANUS HENDERSON GROUP PLC	7.2%	+10%	$648M	6.13M	+594,996	+10.7%	$105.56	13G/A	6/30/2025	14 Aug 2025 11:27:35
JANUS HENDERSON GROUP PLC	6.5%		$321M	5.54M			$57.91	13G	3/31/2025	14 May 2025 11:47:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.28%	+0.03%	$580M	6.13M	+617,516	+11.2%	$94.57	Q2 2025
3/31/2025	0.19%	+0.13%	$346M	5.52M	+3,849,724	+200%	$62.69	Q1 2025
12/31/2024	0.04%	+0.01%	$77.5M	1.67M	+624,370	+59.9%	$46.47	Q4 2024
9/30/2024	0.02%	0%	$30M	1.04M	-49,247	-4.51%	$28.79	Q3 2024
6/30/2024	0.01%	-0.01%	$15.8M	1.09M	-939,952	-46.3%	$14.46	Q2 2024
3/31/2024	0.02%	+0%	$32.7M	2.03M	+228,633	+12.7%	$16.07	Q1 2024
12/31/2023	0.02%	+0%	$35.8M	1.8M	+166,539	+10.2%	$19.87	Q4 2023
9/30/2023	0.02%	+0.01%	$26.7M	1.64M	+1,212,266	+286%	$16.29	Q3 2023
6/30/2023	0.01%	+0%	$8.97M	425K	+201,527	+90.4%	$21.13	Q2 2023
3/31/2023	0%	0%	$4.48M	223K	-315,605	-58.6%	$20.10	Q1 2023
12/31/2022	0.01%	+0%	$14.1M	539K	+238,634	+79.5%	$26.10	Q4 2022
9/30/2022	0%	+0%	$3.07M	300K	+300,000	NEW	$10.23	Q3 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.